Vireo Growth Acquires Majority of Schwazze Convertible Notes for $1.6 Million

Reuters
Dec 30, 2025
<a href="https://laohu8.com/S/VREOF">Vireo Growth</a> Acquires Majority of Schwazze Convertible Notes for $1.6 Million

Vireo Growth Inc. has announced plans to acquire additional outstanding senior secured convertible notes of Medicine Man Technologies Inc., doing business as Schwazze. The company will purchase notes with a total outstanding principal and accrued interest of approximately $2.6 million at a substantial discount, paying around $1.6 million in subordinate voting shares at a price of $0.54 per share. Upon closing, expected later this month and subject to customary conditions and approvals, Vireo will hold about 89% of Schwazze’s outstanding senior secured convertible notes. The share consideration will be subject to customary resale restrictions under Canadian securities law and the rules of the Canadian Securities Exchange.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vireo Growth Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-124843), on December 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10